ICARES Medicus, Inc. (6612) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ICARES Medicus, Inc. (6612:TWSE), powered by AI.

Current Price
$72.70
Sector
Healthcare
What is the ICARES Medicus, Inc. stock price forecast?

ICARES Medicus, Inc. is currently trading at $72.70. View real-time AI analysis on Alpha Lenz.

What is ICARES Medicus, Inc. insider trading activity?

View the latest insider trading data for ICARES Medicus, Inc. on Alpha Lenz.

What is ICARES Medicus, Inc.'s P/E ratio?

View ICARES Medicus, Inc.'s valuation metrics on Alpha Lenz.

ICARES Medicus, Inc.

TWSE · 6612
NT$72.70-0.40(-0.55%)
Ask about ICARES Medicus, Inc.'s future dividend policy...
Alpha Chat Insight

ICARES Medicus, Inc.'s ROE is 2.9%. Explore profitability and growth together.

Ask for details

Company Overview

ICARES Medicus, Inc. is a healthcare company specializing in the research, development, manufacturing, and sale of ophthalmic medical devices and nanomedical materials. The company's primary products include intraocular lenses designed to address various eye conditions such as cataract, myopia, hyperopia, presbyopia, and astigmatism, as well as surgical implant systems and related technical services. In addition to devices for vision correction, ICARES Medicus, Inc. offers advanced nanomedical lubricious coatings and specialized surface treatments for other implantable and interventional medical devices, supporting broader innovation within the medical technology sector. Operating internationally, the company serves markets in Taiwan, China, the United States, Japan, Spain, and England. Founded in 2011 and based in Zhubei City, Taiwan, ICARES Medicus, Inc. contributes to the advancement of healthcare technology by providing essential solutions for ophthalmic surgery and medical device enhancement, positioning itself as a significant player in the global medical instruments and supplies industry.

CEODr. Ih-Houng Loh
SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.13BRevenue
0.00Shares Out
0Employees

Margins

59.08%Gross
21.35%EBITDA
11.36%Operating
5.99%Pre-Tax
0.27%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

30.25%Rev 3Yr
25.54%Rev 5Yr
0.34%Op Inc 3Yr
10.68%Op Inc 5Yr
-69.70%Net Inc 3Yr
-39.19%Net Inc 5Yr

Returns

0.10%ROA
2.93%ROE
2.97%ROIC

Financial Health

NT$459.09MCash & Cash Equivalents
NT$752.59MNet Debt
61.56%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

ICARES Medicus, Inc. (ticker: 6612) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 72.7 with a P/E ratio of -x and P/B of -x.

ROE is 2.93% and operating margin is 11.36%. Annual revenue is $1.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
ICARES Medicus, Inc. (6612) Stock Forecast 2026 $72.70 — Price, Financials & Analyst Targets | Alpha Lenz